Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Faculty

Theodore Abraham, MD, FACC, FASE

Meyer Friedman Distinguished Professor of Medicine
Director
UCSF Adult Cardiac Echocardiography Laboratory
University of California, San Francisco
San Francisco, California

Disclosures

Theodore Abraham, MD, FACC, FASE, has no relevant financial relationships.

Milind Desai, MD, MBA, FACC, FAHA, FESC

Haslam Family Endowed Chair in Cardiovascular Medicine and Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Director
Center for Hypertrophic Cardiomyopathy
Cleveland Clinic Heart, Vascular, and Thoracic Institute
Cleveland, Ohio

Disclosures

Milind Desai, MD, MBA, FACC, FAHA, FESC, has the following relevant financial relationships:
Consultant or advisor for: Bristol Myers Squibb Company; Cytokinetics; Medtronic, Inc.; Tenaya Therapeutics
Research funding from: Bristol Myers Squibb Company; Cytokinetics; Tenaya Therapeutics

Carolyn Y. Ho, MD

Associate Professor of Medicine
Harvard Medical School
Medical Director
Cardiovascular Genetics Center
Brigham and Women's Hospital
Boston, Massachusetts

Disclosures

Carolyn Y. Ho, MD, has the following relevant financial relationships:
Consultant or advisor for: BioMarin Pharmaceutical Inc.; Bristol Myers Squibb Company; Cytokinetics; Lexicon Pharmaceuticals, Inc.; Tenaya Therapeutics; Viz.ai
Research funding from: BioMarin Pharmaceuticals Inc.; Bristol Myers Squibb Company; Cytokinetics; Tenaya Therapeutics; Pfizer, Inc.

Christopher M. Kramer, MD

George A. Beller MD/Lantheus Medical Imaging
Distinguished Professor of Cardiovascular Medicine
University of Virginia Health
Charlottesville, Virginia

Disclosures

Christopher M. Kramer, MD, has the following relevant financial relationships:
Consultant or advisor for: Bristol Myers Squibb Company; Lilly; Xencor, Inc.
Research funding from: Bristol Myers Squibb Company; Cytokinetics; Lilly

Editors

Joy P. Marko, MS, APN-C, CCMEP

Senior Medical Education Director, Medscape, LLC

Disclosures

Joy P. Marko, MS, APN-C, CCMEP, has no relevant financial relationships.

Anne M. Sendaydiego, PharmD

Medical Education Director, WebMD Global, LLC

Disclosures

Anne M. Sendaydiego, PharmD, has no relevant financial relationships.

Compliance Reviewer

Leigh Schmidt, MSN, RN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME / ABIM MOC

Echocardiographic Assessment Across the Hypertrophic Cardiomyopathy Patient Journey: Tips From the Cardiac Sonographer's Playbook

Authors: Theodore Abraham, MD, FACC, FASE; Milind Desai, MD, MBA, FACC, FAHA, FESC; Carolyn Y. Ho, MD; Christopher M. Kramer, MD
CME / ABIM MOC Released: 8/8/2023
Valid for credit through: 8/8/2024, 11:59 PM EST

Start Activity

Credits Available

Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™

ABIM Diplomates - maximum of 1.00 ABIM MOC points

You Are Eligible For
- Letter of Completion
- ABIM MOC points

Target Audience and Goal Statement

This activity is intended for cardiologists, primary care physicians, surgeons, nurse practitioners, physician assistants, and other healthcare professionals involved in the care of patients with HCM.

The goal of this activity is for learners to optimize their use of echocardiology in the screening, diagnosis, management, and follow-up of patients with HCM.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Utility of echocardiography in the diagnosis and prognosis of HCM
- Quantification of left ventricular outflow tract (LVOT) gradients, mitral regurgitation (MR), and left ventricular ejection fraction (LVEF) in the echocardiographic workup of HCM
- Elements of the echocardiography report that should raise suspicion of HCM
- Utility of echocardiography for follow-up and monitoring response to HCM treatment

Disclosures

Faculty

Theodore Abraham, MD, FACC, FASE

Meyer Friedman Distinguished Professor of Medicine
Director
UCSF Adult Cardiac Echocardiography Laboratory
University of California, San Francisco
San Francisco, California

Disclosures

Theodore Abraham, MD, FACC, FASE, has no relevant financial relationships.

Milind Desai, MD, MBA, FACC, FAHA, FESC

Haslam Family Endowed Chair in Cardiovascular Medicine and Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Director
Center for Hypertrophic Cardiomyopathy
Cleveland Clinic Heart, Vascular, and Thoracic Institute
Cleveland, Ohio

Disclosures

Milind Desai, MD, MBA, FACC, FAHA, FESC, has the following relevant financial relationships:
Consultant or advisor for: Bristol Myers Squibb Company; Cytokinetics; Medtronic, Inc.; Tenaya Therapeutics
Research funding from: Bristol Myers Squibb Company; Cytokinetics; Tenaya Therapeutics

Carolyn Y. Ho, MD

Associate Professor of Medicine
Harvard Medical School
Medical Director
Cardiovascular Genetics Center
Brigham and Women's Hospital
Boston, Massachusetts

Disclosures

Carolyn Y. Ho, MD, has the following relevant financial relationships:
Consultant or advisor for: BioMarin Pharmaceutical Inc.; Bristol Myers Squibb Company; Cytokinetics; Lexicon Pharmaceuticals, Inc.; Tenaya Therapeutics; Viz.ai
Research funding from: BioMarin Pharmaceuticals Inc.; Bristol Myers Squibb Company; Cytokinetics; Tenaya Therapeutics; Pfizer, Inc.

Christopher M. Kramer, MD

George A. Beller MD/Lantheus Medical Imaging
Distinguished Professor of Cardiovascular Medicine
University of Virginia Health
Charlottesville, Virginia

Disclosures

Christopher M. Kramer, MD, has the following relevant financial relationships:
Consultant or advisor for: Bristol Myers Squibb Company; Lilly; Xencor, Inc.
Research funding from: Bristol Myers Squibb Company; Cytokinetics; Lilly

Editors

Joy P. Marko, MS, APN-C, CCMEP

Senior Medical Education Director, Medscape, LLC

Disclosures

Joy P. Marko, MS, APN-C, CCMEP, has no relevant financial relationships.

Anne M. Sendaydiego, PharmD

Medical Education Director, WebMD Global, LLC

Disclosures

Anne M. Sendaydiego, PharmD, has no relevant financial relationships.

Compliance Reviewer

Leigh Schmidt, MSN, RN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Cardiology

CME / ABIM MOC

Echocardiographic Assessment Across the Hypertrophic Cardiomyopathy Patient Journey: Tips From the Cardiac Sonographer's Playbook

Authors: Theodore Abraham, MD, FACC, FASE; Milind Desai, MD, MBA, FACC, FAHA, FESC; Carolyn Y. Ho, MD; Christopher M. Kramer, MDFaculty and Disclosures

CME / ABIM MOC Released: 8/8/2023

Valid for credit through: 8/8/2024, 11:59 PM EST

processing....

Contents of this Activity

Clinician Handout

To start this activity, please assess your clinical knowledge by completing the brief survey at the bottom. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

Overview of Echocardiography for HCM Management: Role in Screening and Follow-Up

The faculty introduce the role of echocardiography in the management of HCM.
Theodore Abraham, MD, FACC, FASE; Christopher M. Kramer, MD

Echocardiographic Workup for HCM, Part I: Establishing the Diagnosis and Pattern of Hypertrophy

The faculty review the importance of accurate HCM diagnosis.
Theodore Abraham, MD, FACC, FASE; Carolyn Y. Ho, MD

Echocardiographic Workup for HCM, Part II: Evaluation of Global Myocardial Function and LVOT Obstruction

The faculty discuss the diagnosis of obstructive HCM.
Theodore Abraham, MD, FACC, FASE; Christopher M. Kramer, MD

Echocardiographic Workup for HCM, Part III: Evaluation of Mitral Valve Abnormalities and LV Apical Aneurysm

The faculty review the role of echocardiography in the identification of apical aneurysm.
Theodore Abraham, MD, FACC, FASE; Milind Desai, MD, MBA, FACC, FAHA, FESC

Beyond Diagnosis: Utility of Echocardiography for Risk Stratification

The faculty discuss sudden cardiac death and the importance of risk stratification.
Theodore Abraham, MD, FACC, FASE; Carolyn Y. Ho, MD

Beyond Diagnosis: Utility of Echocardiography to Guide Treatment Decisions

The faculty outline drug therapy options for HCM treatment.
Theodore Abraham, MD, FACC, FASE; Milind Desai, MD, MBA, FACC, FAHA, FESC

Educational Impact Challenge

Please answer the questions below to self-assess your knowledge. Answering these questions again after the activity will allow you to see what you learned.

Page 1 of 9

CME / ABIM MOC Information Download Slides

Activity Transcript

PDF Downloads

Clinician Handout

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Theodore Abraham, MD, FACC, FASE

Milind Desai, MD, MBA, FACC, FAHA, FESC

Carolyn Y. Ho, MD

Christopher M. Kramer, MD

Editors

Joy P. Marko, MS, APN-C, CCMEP

Anne M. Sendaydiego, PharmD

Compliance Reviewer

Leigh Schmidt, MSN, RN, CNE, CHCP

Peer Reviewer

CME / ABIM MOC

Echocardiographic Assessment Across the Hypertrophic Cardiomyopathy Patient Journey: Tips From the Cardiac Sonographer's Playbook

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

Theodore Abraham, MD, FACC, FASE

Milind Desai, MD, MBA, FACC, FAHA, FESC

Carolyn Y. Ho, MD

Christopher M. Kramer, MD

Editors

Joy P. Marko, MS, APN-C, CCMEP

Anne M. Sendaydiego, PharmD

Compliance Reviewer

Leigh Schmidt, MSN, RN, CNE, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Echocardiographic Assessment Across the Hypertrophic Cardiomyopathy Patient Journey: Tips From the Cardiac Sonographer's Playbook

Contents of this Activity

Clinician Handout

Overview of Echocardiography for HCM Management: Role in Screening and Follow-Up

Echocardiographic Workup for HCM, Part I: Establishing the Diagnosis and Pattern of Hypertrophy

Echocardiographic Workup for HCM, Part II: Evaluation of Global Myocardial Function and LVOT Obstruction

Echocardiographic Workup for HCM, Part III: Evaluation of Mitral Valve Abnormalities and LV Apical Aneurysm

Beyond Diagnosis: Utility of Echocardiography for Risk Stratification

Beyond Diagnosis: Utility of Echocardiography to Guide Treatment Decisions

Educational Impact Challenge

PDF Downloads